Amnion-Stem Cell Composite for Nerve Injury Repair
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for nerve injuries and neurological disorders, such as spinal cord injuries, brain trauma, stroke, and dementia, are inadequate in effectively improving symptoms and promoting recovery due to the fragility of nerves and the limited efficacy of existing therapies.
Innovation Solution
The use of compositions comprising an amnion tissue preparation, either with or without viable cells, and a stem cell preparation, administered via injection or as part of a nerve scaffold, to treat nerve injuries and neurological disorders, with the amnion tissue preparation being derived from human amnion tissue and the stem cell preparation containing viable mesenchymal or neural stem cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments are used for nerve injuries and neurological disorders, then treatment simplicity is maintained, but therapeutic efficacy is insufficient
Solution Approach 1:
The patent combines amnion tissue preparation and stem cell preparation into a single composite composition that can be administered together. This merging of two therapeutic agents into one treatment formulation maintains operational simplicity while achieving synergistic therapeutic effects for nerve injury repair, addressing both the efficacy improvement and complexity avoidance needs
2Reliability
If amnion tissue preparation and stem cell preparation are administered separately, then each component can be optimized independently, but treatment procedure becomes more complex
Solution Approach 1:
The patent formulates amnion tissue preparation and stem cell preparation together in a single injectable composition, allowing both therapeutic agents to be administered simultaneously through one procedure. This approach maintains the optimized components while significantly simplifying the administration process and reducing procedural complexity
3Reliability
If existing therapies are used for nerve injuries, then treatment accessibility is maintained, but symptom improvement is limited
Solution Approach 1:
The patent creates a composite therapeutic formulation combining amnion tissue preparation (providing structural support and growth factors) with stem cell preparation (providing cellular regeneration capability). This composite material approach enhances symptom improvement by leveraging the complementary mechanisms of both components while maintaining a unified treatment formulation
Data Source
AI summary
This document provides methods and materials for treating nerve injuries and/or neurological disorders. For example, compositions including an amnion tissue preparation and/or a stem cell preparation as well as methods for using such compositions to treat a nerve injuries and/or neurological disorders are provided.